These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36075765)

  • 1. [Hypertension and cancer : Dangerous Liaisons].
    Duvillier P
    Ann Cardiol Angeiol (Paris); 2022 Nov; 71(5):317-320. PubMed ID: 36075765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension management in cardio-oncology.
    Essa H; Dobson R; Wright D; Lip GYH
    J Hum Hypertens; 2020 Oct; 34(10):673-681. PubMed ID: 32747676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Therapeutics-Related Cardiac Dysfunction　- Insights From Bench and Bedside of Onco-Cardiology.
    Kadowaki H; Akazawa H; Ishida J; Komuro I
    Circ J; 2020 Aug; 84(9):1446-1453. PubMed ID: 32727978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The discipline of onco-cardiology.
    Mouhayar E
    Future Oncol; 2015; 11(14):2027-9. PubMed ID: 26198831
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention.
    Albini A; Pennesi G; Donatelli F; Cammarota R; De Flora S; Noonan DM
    J Natl Cancer Inst; 2010 Jan; 102(1):14-25. PubMed ID: 20007921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension and Prohypertensive Antineoplastic Therapies in Cancer Patients.
    van Dorst DCH; Dobbin SJH; Neves KB; Herrmann J; Herrmann SM; Versmissen J; Mathijssen RHJ; Danser AHJ; Lang NN
    Circ Res; 2021 Apr; 128(7):1040-1061. PubMed ID: 33793337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardio-oncology: conflicting priorities of anticancer treatment and cardiovascular outcome.
    Tilemann LM; Heckmann MB; Katus HA; Lehmann LH; Müller OJ
    Clin Res Cardiol; 2018 Apr; 107(4):271-280. PubMed ID: 29453595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on cardio-oncology.
    Herrmann J; Lerman A
    Trends Cardiovasc Med; 2014 Oct; 24(7):285-95. PubMed ID: 25153017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial hypertension in patients under antineoplastic therapy: a systematic review.
    Katsi V; Magkas N; Georgiopoulos G; Athanasiadi E; Virdis A; Masi S; Kliridis P; Hatziyanni A; Tsioufis C; Tousoulis D
    J Hypertens; 2019 May; 37(5):884-901. PubMed ID: 30624368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment.
    Lenneman CG; Sawyer DB
    Circ Res; 2016 Mar; 118(6):1008-20. PubMed ID: 26987914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From cardio-oncology to cardio-onco-pharmacology: Towards a multidisciplinary approach in the understanding and management of cardiotoxicity.
    Ederhy S; Devos P; Cohen A; Pinna B; Bretagne M; Nguyen LS; Salem JE
    Therapie; 2022; 77(2):197-206. PubMed ID: 34895759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular toxicity of anticancer-targeted therapy: emerging issues in the era of cardio-oncology.
    Raschi E; De Ponti F
    Intern Emerg Med; 2012 Apr; 7(2):113-31. PubMed ID: 22161318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardio-oncology in Austria: cardiotoxicity and surveillance of anti-cancer therapies : Position paper of the Heart Failure Working Group of the Austrian Society of Cardiology.
    Bergler-Klein J; Rainer PP; Wallner M; Zaruba MM; Dörler J; Böhmer A; Buchacher T; Frey M; Adlbrecht C; Bartsch R; Gyöngyösi M; Fürst UM
    Wien Klin Wochenschr; 2022 Sep; 134(17-18):654-674. PubMed ID: 35507087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management.
    Curigliano G; Cardinale D; Dent S; Criscitiello C; Aseyev O; Lenihan D; Cipolla CM
    CA Cancer J Clin; 2016 Jul; 66(4):309-25. PubMed ID: 26919165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Onco-cardiology: Present and future.
    Sueta D; Hokimoto S
    Int J Cardiol; 2016 Jul; 215():38-40. PubMed ID: 27107544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Growing Impact of Cardiovascular Oncology: Epidemiology and Pathophysiology.
    Tufano A; Coppola A; Galderisi M
    Semin Thromb Hemost; 2021 Nov; 47(8):899-906. PubMed ID: 34255338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension in the Cardio-Oncology Clinic.
    Hassen LJ; Lenihan DJ; Baliga RR
    Heart Fail Clin; 2019 Oct; 15(4):487-495. PubMed ID: 31472884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardio-oncological management of patients.
    Cardinale DM; Barac A; Torbicki A; Khandheria BK; Lenihan D; Minotti G
    Semin Oncol; 2019 Dec; 46(6):408-413. PubMed ID: 31784042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arterial hypertension in cancer: The elephant in the room.
    Tini G; Sarocchi M; Tocci G; Arboscello E; Ghigliotti G; Novo G; Brunelli C; Lenihan D; Volpe M; Spallarossa P
    Int J Cardiol; 2019 Apr; 281():133-139. PubMed ID: 30718135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer Therapy-Related Hypertension: A Scientific Statement From the American Heart Association.
    Cohen JB; Brown NJ; Brown SA; Dent S; van Dorst DCH; Herrmann SM; Lang NN; Oudit GY; Touyz RM;
    Hypertension; 2023 Mar; 80(3):e46-e57. PubMed ID: 36621810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.